Buscar resultados de ensayos clínicos
Myopia - 71 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Evaluation of the Prophylactic Use of Mitomycin C 0.02% to Inhibit Haze Formation After Photorefractive Keratectomy for High Myopia: 15 x 30 Seconds Condición: High Myopia Fecha: 2007-11-26 Intervenciones: Drug: PRK and a single intraoperative topical application of mitomycin C 0.02% for 15 seconds Mitomycin |
Completed |
Nombre del estudio: Study of Theories About Myopia Progression (STAMP) Condición: Myopia Fecha: 2006-06-07 Intervenciones:
|
Recruiting |
Nombre del estudio: The Relationship Between Structure and Visual Function in Myopia Foveoschisis Condición: High Myopia Fecha: 2016-09-04 Intervenciones: Procedure: macular buckling surgery Participants with high myopia foveoschisis are scheduled to macular |
Enrolling by invitation |
Nombre del estudio: Time Outdoors as an Intervention for Myopia in Children Condición: Myopia Fecha: 2016-11-21 Intervenciones:
|
Recruiting |
Nombre del estudio: Effect of Orthokeratology Versus Spectacles on Myopia Progression in Chinese Children: A Crossover Trial Condición: Myopia Fecha: 2014-06-29 Intervenciones:
|
Recruiting |
Nombre del estudio: Genomewide Screening of Pathological Myopia Condición: Pathological Myopia Fecha: 2005-09-09 |
Recruiting |
Nombre del estudio: Early Vitrectomy for Macular Tractional Maculopathy Condición: Myopia, Degenerative Fecha: 2010-04-30 Intervenciones: Procedure: Early vitrectomy Triamcinolone acetonide assisted pars plana vitrectomy with Indocyanine gree |
Completed |
Nombre del estudio: Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia Condición: Myopia, Degenerative Fecha: 2013-07-10 Intervenciones:
|
Completed |
Nombre del estudio: Safety and Efficacy Study of Combretastatin A4 Phosphate to Treat Patients With Choroidal Neovascularization Secondary to Pathologic Myopia Condición:
Fecha: 2011-08-22 Intervenciones: Drug: Combretastatin A-4 Phosphate Combretastatin A-4 Phosphate is administered on Day 0 and Day 7 (+/- |
Completed |
Nombre del estudio: Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen Condición: Choroidal Neovascularisation Fecha: 2009-12-21 Intervenciones: Drug: ranibizumab 0.5mg |